KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 334 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $9,398,000 | +143.1% | 29,693 | +29.9% | 0.00% | +100.0% |
| Q3 2023 | $3,866,000 | +62.0% | 22,863 | +107.8% | 0.00% | 0.0% |
| Q2 2023 | $2,386,000 | +8.2% | 11,001 | -9.4% | 0.00% | 0.0% |
| Q1 2023 | $2,205,000 | -3.7% | 12,143 | +4.2% | 0.00% | 0.0% |
| Q4 2022 | $2,290,000 | +99.3% | 11,657 | +128.2% | 0.00% | – |
| Q3 2022 | $1,149,000 | +4003.6% | 5,109 | +2254.4% | 0.00% | – |
| Q2 2022 | $28,000 | -84.3% | 217 | -84.6% | 0.00% | – |
| Q1 2022 | $178,000 | -73.2% | 1,407 | -72.3% | 0.00% | – |
| Q4 2021 | $665,000 | +161.8% | 5,073 | +144.4% | 0.00% | – |
| Q3 2021 | $254,000 | -41.7% | 2,076 | -45.7% | 0.00% | – |
| Q2 2021 | $436,000 | +254.5% | 3,824 | +273.8% | 0.00% | – |
| Q1 2021 | $123,000 | +623.5% | 1,023 | +501.8% | 0.00% | – |
| Q4 2020 | $17,000 | +466.7% | 170 | +254.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |